Christopher Aker - Sr. VP & General Counsel at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Sr. VP & General Counsel
Stock Symbol
RGLS on Nasdaq
All Insider Reports
All Insider Reports

Christopher Aker - trading volume in the past year for Regulus Therapeutics Inc.

Holdings reported by Christopher Aker for Regulus Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10.1K $12K $1.19 Jan 18, 2024 Direct
Stock Option (Right to Buy) 363K May 20, 2024 Direct Common Stock

Transactions reported by Christopher Aker for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.